美国Certara Pharsight 
Pharsight公司则是临床药物研究领域为提高产率及制定决策所需软件及服务方面的顶级供应商。
Pharsight®, a Certara™ company, is a market-leading provider of software products and scientific consulting services to help pharmaceutical and biotechnology companies improve their drug development process, regulatory compliance and strategic decision-making. Established in 1995, the company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Headquartered in St. Louis, Missouri, Pharsight has offices in Mountain View, California; Cary, North Carolina; Montreal, Canada; Munich, Germany; and staff throughout the United States and Europe.

Our management, consulting services and technical staff have a broad range of expertise and experience in key drug development disciplines including clinical pharmacology, drug and disease modeling, human genetics, biostatistics, strategic decision-making, regulatory strategy, clinical development and information technology.

We have a rapidly growing customer base of companies that use Pharsight's products and services. All of the world's largest 50 pharmaceutical companies license at least one of Pharsight's computer-assisted drug development products, and 22 of the world's top 50 pharmaceutical firms currently utilize the company's Strategic Consulting Services group in multiple therapeutic areas. Pharsight's Reporting and Analysis Services group serves a growing client base with high-quality PK/PD data analyses and report writing for pre-clinical and clinical studies to support new drug submission and approval.